Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Active not recruiting × pegaspargase × Clear all

Phase

Phase 3 8 Phase 1/2 3 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Completed 8 Withdrawn 2 Terminated 2 Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Burkitt Lymphoma 1

Interventions

pembrolizumab 81 Cyclophosphamide 69 Nivolumab 53 fludarabine 43 Specimen Handling 38 Carboplatin 36 Magnetic Resonance Spectroscopy 34 Biopsy 31 fludarabine phosphate 27 Radiotherapy 25 Paclitaxel 25 Cisplatin 25 Gemcitabine 24 atezolizumab 23 venetoclax 22 Radiosurgery 21 Ipilimumab 19 durvalumab 18 Radiation 18 Dexamethasone 17 Bevacizumab 17 Rituximab 16 Temozolomide 15 Lenalidomide 15 Injections 14 Docetaxel 14 Decitabine 14 Pemetrexed 13 Irinotecan 13 Fluorouracil 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03962465 2023-08-22

ALL-001

University of Virginia

Phase 1 Active not recruiting

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡